COMMERCIAL MANUFACTURING and PACKAGING AGREEMENT (Phentermine Hydrochloride and Topiramate capsules)And Packaging Agreement • July 23rd, 2012 • Vivus Inc • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 23rd, 2012 Company Industry JurisdictionThis Commercial Manufacturing and Packaging Agreement (“Agreement”) is made as of this 17th day of July, 2012 (“Effective Date”), by and between VIVUS, Inc., a Delaware corporation, with a place of business at 1172 Castro St., Mountain View, CA 94040 (“Client”), and Catalent Pharma Solutions, LLC, a Delaware limited liability company with a place of business at 14 Schoolhouse Road, Somerset, New Jersey 08873, USA (“Catalent”).
EXHIBIT 10.13(c) TOLL MANUFACTURING AND PACKAGING AGREEMENT This Toll Manufacturing and Packaging Agreement (this "Agreement") is made as of this 31st day of October, 2000, by and between Cephalon, Inc., 145 Brandywine Parkway, West Chester, PA...And Packaging Agreement • March 30th, 2001 • Cephalon Inc • Pharmaceutical preparations
Contract Type FiledMarch 30th, 2001 Company Industry
ContractAnd Packaging Agreement • January 24th, 2005 • LEM America, Inc • Services-amusement & recreation services • New York
Contract Type FiledJanuary 24th, 2005 Company Industry JurisdictionCERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY ASTERISKS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED.
EX-10.12 9 dex1012.htm SOFTGEL COMMERCIAL MANUFACTURING AND PACKAGING AGREEMENT ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 230.406....And Packaging Agreement • May 5th, 2020 • New Jersey
Contract Type FiledMay 5th, 2020 JurisdictionThis Softgel Commercial Manufacturing and Packaging Agreement (“Agreement”) is made this 21st day of March, 2011, by and between Catalent Pharma Solutions, LLC, a Delaware limited liability company, having a place of business at 14 Schoolhouse Road, Somerset, New Jersey 08873 (“Catalent”) and Insys Therapeutics, Inc., a Delaware corporation, having its principal place of business at 10220 S. 51st Street, Suite 2, Phoenix, AZ 85044 (“Client”).